VietNamNet Bridge – Vietnam will continue clamping down on drug violations, after imposing fines on dive local pharmaceutical firms who were discovered importing and marketing bad medicines.
![]() |
|
The Ministry of Health’s Drug Administration head Truong Quoc Cuong said all medicines that failed to meet standards as registered in firms’ circulation dossiers would be recalled and such firms would have new registration numbers for products stopped. Also, any company importing and marketing low-quality medicines would face heavy punishment.
“In the coming time we will continue boosting inspections and investigations of drug firms. Any violation will be punished within the full force of law. Many violations have already been discovered and were met with heavy punishment,” he said.
Last week Cuong signed five decision to impose a fine of VND100 million ($4,761) on each of four local state-owned pharmaceutical firms, including National Phytopharma Joint-Stock Company (Phytopharma), Danang Pharmaceutical Medical Equipment Joint Stock Company (Dapharco), Central Pharmaceutical Company No1’s (CPC1) Ho Chi Minh City branch, and Central Pharmaceutical Company No3 (CPC3), as well as one local private pharmaceutical firm Sohaco Trading and Pharmaceutical Group JSC (Sohaco).
The violators were found to have imported and marketed substandard medicines into Vietnam. The medicines are made mostly by Indian firms (see box).
The administration has also stopped receiving and considering Sohaco’s, Phytopharma’s, CPC3’s and Dapharco’s dossiers requesting imports for the next six months.
It has also stopped CPC1 from importing medicines for one month.
India-based pharmaceutical firm XL Laboratories Pvt., Ltd has also had its products banned permanently from being marketed in Vietnam due to their low quality.
Name of violator |
Name of medicine |
Specification |
Name of producer |
National Phytopharma Joint-Stock Company (Phytopharma) |
Paracetamol infusion |
Vena infusion solution |
India’s Marck Biosciences |
Union Dexamethason |
Injectant |
South Korea’s Union Korea Pharm Co.Ltd. |
|
Hepnol |
Supporting the treatment of liver disease |
India’s Cure Medicines |
|
Umecorn |
Treating adrenal failure |
India’s Umedica Laboratories |
|
Danang Pharmaceutical-Medical Equipment Joint Stock Company (Dapharco) |
Mexid 625 |
Anti-bacterial contamination |
India’s Minimed Laboratories |
Miracef 100 |
Anti-bacterial contamination |
Miracle Labs, |
|
Nilsu |
Treating gastroesophageal reflux disease, which is a disorder that results from stomach acid moving backward from the stomach into the esophagus |
Cure Medicines |
|
Linmycine |
Treating anti-bacterial contamination |
India’s Umedica Laboratories. |
|
Central Pharmaceutical Company No1’s (CPC1) Ho Chi Minh City branch |
Proexen made by |
Anti-bacterial contamination |
South Korea’s Dea Han New Pharm Company |
Norash-20g |
Sun scream |
India’s Raptakos and Brett Company. |
|
Atorvastatin 10mg |
Reducing lipid in blood |
India’s Santa Pharma Generix |
|
Lomindus |
Treating disgestive disorder |
India’s Penta Labs |
|
Markime 100 |
Treating anti-bacterial contamination |
India’s Marksans Pharma |
|
Clavophynamox 625 |
Treating anti-bacterial contamination |
India’s Flamingo Pharmaceuticals |
|
Central Pharmaceutical Company No3 (CPC3) |
H.Pykotif Kit |
Anti-bacterial contamination |
India’s Cure Medicines |
Cefpodoxime |
Anti-bacterial contamination |
India’s XL Laboratories |
|
Coldrid |
Headache treatment |
India’s Medley Pharmaceuticals |
|
Pantosyn |
Treating stomach ulcers |
India’s Syncom Formulations |
|
Sohaco Trading and Pharmaceutical Group JSC (Sohaco). |
Kandimex |
Gynaecological treatment |
India’s M/s MedEx Laboratories |
Tricima 250 |
Anti-bacterial contamination |
India’s Celogen Pharma |
|
Furomarksans 750 |
Injectant |
India’s Marksans Pharma |
VIR